Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VETmAb Biosciences
San Diego, California, United Statesvetmab.bio ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Currently developing monoclonal antibody therapies for dogs and cats, with clinical trials coming soon
- Therapeutic areas
- Other
- Modalities
- Monoclonal antibodies (mAbs)Bispecific antibodies
- Industry
- Veterinary
Sources
- Company website
- Other public source
- Other public source
- Other public source
- Other public source
- Company website
- Other public source
- Other public source
- Company website
Full sources are available to Gosset users. Log in to see them.
Beyond the preview
Go deeper on VETmAb Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VETmAb Biosciences.
Work at VETmAb Biosciences? Claim this page to correct or add information. Claim this page